.

Dr. Afshan Ahmad

I joined Aston Medical School in 2014 as a Teaching Fellow to head up recruitment of General Practices for Community Health teaching of medical students. I am also the Director of Research and Development for Vaccine Research International Plc which I helped establish in 2002 and which has developed a vaccine against Staphylococcal infections which has undergone a successful Phase I clinical trial.

After graduating, I started my research career at Birmingham University in hospital infection and then moved on to vaccine research. 

  • Position: Teaching Fellow 
  • Phone Number: 0121 204 5254
  • Email: a.afshan@aston.ac.uk
  • Room Number: MB510a
  • BSc Immunology/Microbiology, Chelsea College, University of London. 1983.
  • MSc Medical Microbiology, University of Birmingham. 1994.
  • PhD Medical Microbiology, University of Birmingham. 1999.

 

  • 2014 – date: Teaching Fellow, Aston Medical School, Aston University.
  • 2002 – date: Director of Research and Development, Vaccine Research International Plc, Birmingham.
  • 1995 – 2002: Research Associate, Department of Infection, University of Birmingham.
  • 1993 – 1995: Research Associate, Arthritis and Rheumatism Council, Department of Infection, University of Birmingham.
  • 1984 – 1993: Research Scientist/ Research Associate, Department of Infection, University of Birmingham

 

I was involved in supervision of BSc students from Biochemistry, Biological Sciences. Biomedical Sciences, Biomaterial Sciences doing final year projects in the Department of Infection, Medical School, University of Birmingham and also with supervision of MSc students from Biochemistry, Biomedical Sciences and Toxicology. I also gave technical help to PhD students and Medical students doing intercalated BScs in the same laboratory.

My research career has involved work mainly in the development of a Staphylococcal vaccine and application of that method to vaccines against other organisms for example Streptococci and Dermatophilus. This involved laboratory work and studies investigating the immune response of vaccinated patients in Italy and the United Kingdom. I have also been instrumental in organisation and prosecution of a Phase I clinical trial of the Staphylococcus aureus vaccine.

I contributed to the Birmingham City Council Scrutiny review on Methicillin Resistant Staphylococcus aureus (MRSA) and was involved in reviewing the resulting Report of the Committee to Birmingham City Council in 2005.

I have also worked in research to develop antiviral compounds.

Fundraising through shareholders to establish Vaccine Research International Plc in 2002 and subsequent fundraisings through the same funding source; latest in 2013. 
Society for General Microbiology
  • GRB Skinner, M Billstrom, S Randall, A Ahmad, S Patel, J Davies, A Deane. A system for isolation, transport, and storage of herpes simplex viruses. Journal of Virological Methods. 1997. Vol  65: 1-8. 
  • J Benitez, J Davies, A Ahmad, GRB Skinner. Environmental influence on immune inhibition of release (IVR) of herpes simplex virus from cells. Intervirology. 1998. Vol   41: 120-126.
  • GRB Skinner, M Billstrom, A Buchan, J Davies, A Ahmad. Antiviral efficacy of disinfectant solution MRI-1. Intervirology. 1998. Vol  41(6) 238-243. 
  • G R B Skinner, D Holmes, A Ahmad, J Davies and J Benitez. Clinical response to thyroxine sodium in clinically hypothyroid but biochemically euthyroid patients.  Journal of Nutritional and Environmental Medicine  2000. Vol   10 115-124.
  • GRB Skinner, A Ahmad, A Zafar, MG Hullin, D Dick. Case report: vaccination against Staphylococcal infection prior to tertiary knee joint replacement. Orthopaedics.2001. Vol   24 (3)289-291.
  • GRB Skinner, A Ahmad, JA Davies. The infrequency of transmission of herpesviruses between humans and animals; postulation of an unrecognised protective host mechanism. Comparative Immunology Microbiology and Infectious Diseases. 2001. Vol   24: 255-269.